Common Mistakes We've Seen (And How to Sidestep Them) Over the years, our team has helped thousands of researchers, and we've seen a few common missteps that can compromise results
Available from: Deehan M, Garcs S, Kramer D, Baker MP, Rat D, Roettger Y, et al
In a head-to-head clinical trial, Saxenda users lost an average of 6.4% of their body weight after 68 weeks, while Wegovy users lost 15.8%
As a well-documented GHK-Cu copper binding peptide, it is commonly used in experimental settings to explore wound healing mechanisms and cellular signaling pathways
& Ou, C
The work below comes from preclinical studies, not from proven effects in people